Found 8 hits for monomerid = 50311911 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 458 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of SRC |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of LCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Insulin receptor
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused InsR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 185 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused KDR expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LCK expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase Lyn
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 113 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused LYN expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 527 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of Tel-fused SRC expressed in mouse BAF3 cells |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase HCK
(Homo sapiens (Human)) | BDBM50311911
(4-methyl-3-(1-(6-(2-(4-methylpiperazin-1-yl)ethyla...)Show SMILES CN1CCN(CCNc2cc(ncn2)-n2c(Nc3cc(ccc3C)C(=O)Nc3cccc(c3)C(F)(F)F)nc3ccccc23)CC1 Show InChI InChI=1S/C33H34F3N9O/c1-22-10-11-23(31(46)40-25-7-5-6-24(19-25)33(34,35)36)18-27(22)42-32-41-26-8-3-4-9-28(26)45(32)30-20-29(38-21-39-30)37-12-13-44-16-14-43(2)15-17-44/h3-11,18-21H,12-17H2,1-2H3,(H,40,46)(H,41,42)(H,37,38,39) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Genomics Institute of the Novartis Research Foundation (GNF)
Curated by ChEMBL
| Assay Description Inhibition of HCK |
Bioorg Med Chem Lett 19: 6691-5 (2009)
Article DOI: 10.1016/j.bmcl.2009.09.123 BindingDB Entry DOI: 10.7270/Q2Q52PRR |
More data for this Ligand-Target Pair | |